We examined the effects of b2-adrenergic receptor (b2-AR) agonists on the expression of co-stimulatory molecules on lipopolysaccharide (LPS)-stimulated human peripheral blood mononuclear cells. The study found that b2-AR agonists inhibited the expression of intercellular adhesion molecule-1 (ICAM-1), CD40 and CD14 on monocytes, and that AR agonist activity was antagonized by the selective b2-AR antagonist, butoxamine. The selective b2-AR agonists salbutamol and terbutaline induced a similar co-stimulatory molecule expression pattern. The LPS-induced production of tumour necrosis factor-a was inhibited by AR agonists, and this was also antagonized by butoxamine, and mimicked by salbutamol and terbutaline. The AR agonists also inhibited T-cell proliferation through b2-AR stimulation. This study clearly demonstrated that endogenous catecholamines elicited immunosuppressive effects through b2-AR stimulation, possibly due to downregulation of the expression of ICAM-1, CD40 and CD14 on monocytes. These results suggested that the sympathetic nervous system might regulate the Thelper cell balance via the peripheral endeffectors of the stress system.
Introduction
Antigen presenting cell (APC)-derived costimulatory signals are required for eliciting maximal T-cell growth, differentiation and cytokine production. The interaction of intercellular adhesion molecule-1 (ICAM-1) on APCs with lymphocyte function-associated antigen (LFA-1) on T-cells, as well as that of B7.1 and B7.2 with CD28, produces important co-stimulatory signals. 1 -3 In addition, CD40 co-stimulatory molecules on APCs bind to T-cell CD40 ligand (CD40L). 4 The stimulation of CD40 on monocytes by CD40L on T-cells induces interleukin (IL)-12 production by monocytes. 5 Blockade of the co-stimulatory signals, including ICAM-1/LFA-1, B7/CD28 and CD40/CD40L, has considerable potential for anti-inflammatory and immunosuppressive effects. 6 -11 Lipopolysaccharide (LPS), a major component of the outer membrane of Gram-negative bacteria, is a key molecule in the pathophysiology of endotoxic shock. 12 In mammals, monocytes/macrophages primarily respond to LPS and release tumour necrosis factor (TNF)-α, which is a mediator for the development of septic shock. 13, 14 The primary receptor for complexes of LPS and LPS-binding protein (LBP) is CD14, and it is expressed mainly on the cell surface of monocytes/macrophages. 15 Complexes of LPS-CD14 initiate intracellular signalling by binding to the recently defined membrane proteins, the toll-like receptors (TLR). 16 Toll-like receptor-4 (TLR-4) has been demonstrated to be involved in LPS-induced signal transduction, 17, 18 and TLR-4 requires CD14 to participate in the process of LPS-induced signalling. 19 All organs contain neurons from the sympathetic division of the autonomic nervous system. An increase in the sympathetic activity induces the release of noradrenaline into sites that are rich in T-cells and macrophages. 20 Noradrenaline in turn has effects on immune cells through the stimulation of adrenergic subtype receptors. 21 The β-adrenergic receptor (β-AR) is now subdivided into three subtypes: β1, β2 and β3. Monocytes are very responsive to β2-AR stimulation, with regard to cyclic adenosine monophosphate (cAMP) accumulation, while T-and B-cells show only a modest response. 22 A recent report showed that noradrenaline and adrenaline inhibited the production of human IL-12 and TNF-α, whereas they did not affect the production of IL-10, 23 indicating that through this mechanism these mediators might cause a selective suppression of T-helper (Th) 1 responses and a Th2 shift rather than a generalized T-helper suppression. Little is known about the underlying mechanisms, however.
We examined the effects of noradrenaline, adrenaline and isoproterenol on the expression of CD14, TLR-4, ICAM-1, B7.1, B7.2, CD40 and CD40L in human monocytes treated with LPS. We also investigated the effects of the selective β2-AR agonists, salbutamol and terbutaline, on the expression of CD14, ICAM-1 and CD40 in LPS-treated human monocytes. The effects of endogenous catecholamines and selective β2-AR agonists on TNF-α production by peripheral blood mononuclear cells (PBMC) treated with LPS and T-cell proliferation were also studied.
Materials and methods

REAGENTS AND DRUGS
Lipopolysaccharide (from Escherichia coli 026:B6) was purchased from Sigma (St. Louis, MO, USA). Adrenaline, noradrenaline, isoproterenol, salbutamol, terbutaline, prazosin, yohimbine, atenolol and butoxamine were purchased from Sigma. Human anti-CD40 monoclonal antibody (mAb; mouse IgG1) was purchased from Pharmingen (San Diego, CA, USA). Anti-CD40L/CD154 mAb (mouse IgG1) was purchased from Ancel (Bayport, MN, USA). MOPC 21, an IgG1 class-matched control (CMC), was purchased from Sigma. Phycoerythrin (PE)-conjugated anti-CD3, anti-CD14 and anti-CD19 mAbs, and FITC-conjugated mouse IgG1 mAb against CD54 (6.5B5), were purchased from DAKO (Glostrup, Denmark). FITC-conjugated mouse IgG1 mAb against B7.1 (MAB104) was purchased from Immunotech (Marseilles, France). FITC-conjugated mouse IgG1 mAb against B7.2 (2331FUN-1) was purchased from Pharmingen. FITC-conjugated anti-TLR-4 Ab was purchased from MBL (Nagoya, Japan). FITC-conjugated MOPC 21, an IgG1 CMC, was purchased from Sigma.
ISOLATION OF PERIPHERAL BLOOD MONONUCLEAR CELLS
Normal human PBMC were obtained from 10 volunteers after obtaining oral informed consent. A sample of peripheral blood (20 -50 ml) was withdrawn from a forearm vein from each volunteer. The PBMC were isolated from the buffy coat by centrifugation on Ficoll-Paque (Pharmacia, Uppsala, Sweden), then washed three times in RPMI-1640 medium (Nissui Co. Ltd., Tokyo, Japan) supplemented with 10% (v/v) heatinactivated fetal calf serum (FCS; 10% FCS RPMI-1640), 20 µg/ml of kanamycin and 100 µg/ml of streptomycin and penicillin (Sigma). The PBMC were suspended at a final concentration of 1 × 10 6 cells/ml.
PREPARATION OF MONOCYTES
Peripheral blood mononuclear cells were prepared as described above. Separation of the cells in each phase of the cell cycle was conducted by counterflow centrifugal elutriation using the SRR6Y elutriation system and a rotor equipped with a 4.5-ml chamber (Hitachi Koki Co. Ltd., Tokyo, Japan). An initial flow rate of 10 ml/min, temperature of 4 o C and rotor speed of 200 g were used. PBMC re-suspended to a concentration of 5 -10 × 10 7 cells per 10 ml of phosphate buffered saline (PBS) supplemented with 1% (v/v) FCS were injected. The flow rate was incrementally increased, and cell fractions were collected serially as follows: fraction 1 (fr. 1), 200 ml at 10 ml/min; fr. 2, 200 ml at 12 ml/min; fr. 3, 200 ml at 14 ml/min; fr. 4, 200 ml at 16 ml/min; and fr. 5, 200 ml at 18 ml/min. The cell population of each fraction was determined by flow cytometry with FITC-conjugated anti-CD14 Ab (monocytes), PE-conjugated anti-CD3 Ab (T-cells) and PE-conjugated anti-CD19 Ab (B-cells). Fractions 3 and 4, determined as monocytes, contained 85% monocytes but less than 5% T-and B-cells.
CYTOKINE ASSAYS
Peripheral blood mononuclear cells or monocytes (1 × 10 6 cells/ml) were incubated with IL-18, noradrenaline, adrenaline, isoproterenol, selective α1-, α2-, β1-, β2-AR agonists, selective α1-, α2-, β1-, β2-AR antagonists and MOPC21 for 24 h at 37 o C, in a 5% CO 2 /air mixture under different conditions. Reagents were added to the media at the start of incubation. After culture, the cell suspensions were transferred into eppendorf tubes and centrifuged. The cell-free supernatant fractions were assayed for TNF-α protein. Cytokine levels were measured using enzyme-linked immunosorbent assays (ELISAs) employing the multiple Abs sandwich principle (Quantikine, R & D Systems, Minneapolis, MN, USA). The detection limit of the ELISA for TNF-α was 10 pg/ml. The results are expressed as the mean ± SEM of five donors.
FLOW CYTOMETRIC ANALYSIS
Monocytes (1 × 10 6 cells/ml) were incubated with β2-adrenoreceptor agonists for 24 h at 37 o C, in a 5% CO 2 /air mixture under different conditions. Reagents were added to the media at the start of incubation. The cells (5 × 10 5 cells/sample) were washed once with washing buffer (PBS supplemented with 2.5% normal horse serum, 0.1% NaN 3 and 0.01 M HEPES, pH = 7.3). Then, the cells were Immunosuppressive effects of b2-adrenergic receptor stimulation on monocytes incubated with 1 µg of FITC-conjugated anti-ICAM-1 Ab, anti-CD40 Ab, anti-CD40L Ab or CMC for 20 min at 4 o C. After washing, monocytes were fixed with 2% paraformaldehyde and analysed with a FACSCalibur (Becton Dickinson Biosciences, San José, CA, USA), and data were processed using the CELL QUEST program (Becton Dickinson Biosciences). The data are expressed as the relative fluorescence intensities against CMC. The results are expressed as the means ± SEM of five donors. 
PROLIFERATION ASSAY
STATISTICAL ANALYSIS
The statistical significance of any differences observed following treatment was evaluated by ANOVA, followed by the Student's twotailed t-test. A P-value < 0.05 was considered significant.
Results
EFFECT OF AR AGONISTS AND AR ANTAGONISTS ON LPS-INDUCED CD14 AND TLR-4 EXPRESSION ON MONOCYTES
The effects of noradrenaline, adrenaline and isoproterenol (0 -10 -4 M) on the change in expression of TLR-4 and CD14 on monocytes were examined by flow cytometry 24 h after the start of incubation. While noradrenaline, adrenaline and isoproterenol had no effect on LPS-induced TLR-4 expression on mono-cytes, these catecholamines inhibited LPS-induced CD14 expression on monocytes in a concentration-dependent manner ( Fig. 1) .
We investigated the blocking effects of four subtypes of AR antagonists, prazosin (α1-AR antagonist), yohimbine (α2-AR antagonist), atenolol (β1-AR antagonist) and butoxamine (β2-AR antagonist) (0 -10 -4 M), on the expression of CD14 induced by LPS (1 ng/ml) in the presence of adrenaline, noradrenaline and isoproterenol (10 -4 M). Butoxamine antagonized the inhibitory effects of adrenaline, noradrenaline and isoproterenol on LPSinduced CD14 expression on monocytes in a concentration-dependent manner (Fig. 2) . In contrast, the same concentrations of prazosin, yohimbine and atenolol did not produce any antagonizing action on the effects of adrenaline, noradrenaline and isoproterenol (Fig. 2) .
The effects of two selective β2-AR agonists (salbutamol and terbutaline; 0 -10 -4 M) on LPS-induced CD14 expression on monocytes were examined. Both salbutamol and terbutaline suppressed LPS-induced CD14 expression in a concentration-dependent manner ( Fig. 3 ).
EFFECT OF AR AGONISTS AND AR ANTAGONISTS ON LPS-INDUCED ICAM-1, B7.1, B7.2, CD40 AND CD40L EXPRESSION ON MONOCYTES
We investigated the effects of different concentrations (0 -10 -4 M) of adrenaline, noradrenaline and isoproterenol on LPSinduced ICAM-1, B7.1, B7.2, CD40 and CD40L expression on monocytes after 24 h incubation. Noradrenaline, adrenaline and isoproterenol had no effect on LPS-induced B7.1, B7.2 and CD40L expression on monocytes (data not shown). The same concentration range of these AR agonists inhibited the expression of ICAM-1 and CD40 on monocytes induced by LPS in a concentrationdependent manner, however ( Fig. 4 ). Immunosuppressive effects of b2-adrenergic receptor stimulation on monocytes Butoxamine (0 -10 -4 M) antagonized the inhibitory effects of noradrenaline, adrenaline and isoproterenol (10 -4 M) on ICAM-1 and CD40 expression on monocytes induced by LPS in a concentration-dependent manner (Fig. 5) . In contrast, the same concentrations of prazosin, yohimbine and atenolol did not produce any antagonizing action on the effects of adrenaline, noradrenaline and isoproterenol (Fig. 5) .
The effects of two selective β2-AR agonists (salbutamol and terbutaline; 0 -10 -4 M) on LPS-induced ICAM-1 and CD40 expression on monocytes were examined. Both β2-AR agonists inhibited LPS-induced ICAM-1 and CD40 expression in a concentrationdependent manner (Fig. 6 ).
EFFECT OF AR AGONISTS AND AR ANTAGONISTS ON LPS-INDUCED TNF-a PRODUCTION BY PBMC
The effect of noradrenaline, adrenaline and isoproterenol (0 -10 -4 M) on LPS-induced TNF-α production was determined after 24 h incubation. Noradrenaline, adrenaline and isoproterenol suppressed LPS-induced TNF-α production in a concentration-dependent manner (Fig. 7) .
Butoxamine (0 -10 -4 M) antagonized the inhibitory effects of noradrenaline, adrenaline and isoproterenol (10 -4 M) on LPS-induced TNF-α production in a concentration-dependent manner (Fig. 8) . In contrast, the other selective AR antagonists showed no antagonistic activity (Fig. 8 ). The effects of two selective β2-AR agonists (salbutamol and terbutaline; 0 -10 -4 M) on LPS-induced TNF-α production in PBMC were examined. Both selective β2-AR agonists inhibited LPS-induced TNF-α production in PBMC in a concentration-dependent manner (Fig. 9 ).
EFFECT OF AR AGONISTS AND AR ANTAGONISTS ON LPS-INDUCED T-CELL PROLIFERATION
The effect of noradrenaline, adrenaline and isoproterenol (0 -10 -4 M) on LPS-induced T-cell proliferation was determined by [ 3 H]-thymidine uptake after 48-h incubation. Noradrenaline, adrenaline and isoproterenol suppressed LPS-induced T-cell proliferation in a concentration-dependent manner (Fig. 10) .
Butoxamine (0 -10 -4 M) antagonized the inhibitory effects of noradrenaline, adrenaline and isoproterenol (10 -4 M) on LPS-induced T-cell proliferation, but the α1-, α2and β1-AR antagonists did not (Fig. 11) .
The selective β2-AR agonists (salbutamol and terbutaline) (0 -10 -4 M) mimicked the modulatory effects of noradrenaline, adrenaline and isoproterenol on LPS-induced T-cell proliferation (Fig. 12 ).
Discussion
The existence of bi-directional communication pathways between the central nervous system (CNS) and the immune system has been well established in recent years. Catecholamines modulate cellular and humoral immunity via adrenoceptors expressed on immune cells. Modulation of immune functions via adrenergic pathways may have important clinical implications, as suggested by findings that stress is 477 K Kuroki, HK Takahashi, H Iwagaki et al. Immunosuppressive effects of b2-adrenergic receptor stimulation on monocytes associated with disease activity in infectious, neoplastic, allergic and certain autoimmune diseases. 20, 23, 24 The biological mechanisms underlying these effects remain largely unknown, however. 25, 26 One possible mode of interaction involves sites of direct contact between cells of the peripheral nervous system and cells of the immune system. All primary and secondary lymphoid organs contain the termini of neurons from the sympathetic division of the autonomic nervous system. 20, 27 When activated by stress or other stimuli, these neurons release micromolar quantities of noradrenaline into sites that are rich in T-cells and macrophages. 20, 28 Adrenoceptor ligation alters several aspects of T-cells in vitro, including cellular activation, cytokine production, cell traffic and adhesion, and cytotoxic activity. 29 -33 Little is known about the effects of catecholamines on the expression of various co-stimulatory molecules on monocytes/ macrophages, however.
We found that AR agonists, noradrenaline, adrenaline and isoproterenol down-regulated the expression of LPS-induced CD14, ICAM-1 and CD40 in a dose-dependent manner, but did not effect TLR-4, B7.1, B7.2 and CD40L expression after 24 h incubation. The modulatory effect of these AR agonists on CD14, ICAM-1 and CD40 expression was antagonized by a β2-AR antagonist, but not by α1-, α2or β1-AR antagonists. The study found that β2-AR selective agonists down-regulated LPS-induced CD14, ICAM-1, and CD40 expression on monocytes. In the same manner, we clearly demonstrated that β2-adrenergic stimulation inhibited LPS-induced TNF-α production and T-cell proliferation.
As described above, CD14 is the primary receptor for complexes of LPS and LBP. 15
K Kuroki, HK Takahashi, H Iwagaki et al. Immunosuppressive effects of b2-adrenergic receptor stimulation on monocytes
Complexes of LPS-CD14 initiate the intracellular signalling by binding to TLR-4, which is involved in LPS-induced signal transduction. 15 -19 Our finding that AR agonists decreased LPS-induced TNF-α production (which was consistent with previous reports) 23, 34, 35 was ascribable, at least in part, to the down-regulation of CD14 expression through the stimulation of β2-AR. It has been reported that TNF-α promotes Th1 responses and cellular immunity, whereas IL-10 suppresses Th1 activities and stimulates Th2 and humoral immune responses. 23 We did not analyse the modulatory effect of AR agonists on IL-10 production, but previous reports showed that noradrenaline increased anti-inflammatory cytokines, such as IL-10 and IL-4. 23,34 -37 It is tempting to speculate that noradrenaline and/or adrenaline released from sympathetic axon terminals and in an enhanced concentration in close proximity to immune cells can inhibit production of pro-inflammatory cytokines (TNF-α, IL-12, IL-1). It is also possible that they increase anti-inflammatory cytokines (IL-10, IL-4) in response to LPS. This indicates a fine-tuning control of the production of TNF-α and other cytokines by sympathetic innervation under stressful conditions. The present study reconfirmed that these effects are mediated via β2-AR, and β2-AR agonists induced a shift in the human Th1/Th2 cytokine balance toward a Th2 response.
The present research clearly shows that AR agonists inhibited the LPS-induced T-cell proliferation through β2-AR stimulation on monocytes. These effects were suggested to be secondary effects induced by downregulation of ICAM-1 and CD40 expression on monocytes, resulting in decreased T-cell activation through decreased cell-to-cell interaction.
In conclusion, this study suggests that the early and innate response to antigens seems to involve the local sympathetic nervous system, which may impact on cytokine production by monocytes/macrophages and the ensuing Th2 shift through β2-AR stimulation. Our findings may provide a rationale for the stress-induced susceptibility of the organism to certain infections. Through the same or a reciprocal mechanism, states associated with chronic hyperactivity or hypoactivity of the stress system might influence the susceptibility of an individual to certain autoimmune, allergic, infectious or neoplastic diseases. Further studies should aim to determine the mechanisms and the pathophysiological implications of this surprising neuroimmunological connection. 
